Kobayashi Pharmaceutical Co.,Ltd.TSE 4967

小林製薬株式会社 · Chemicals · FY ends Dec

Share price at FY-end
¥5,426
FY ending Dec 2025
Market cap at FY-end
¥423B
Dividend per share
¥104.0
Avg. director pay
¥32.0M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 Akihiro Kobayashi 9,264,000 12.46% ¥50.3B ¥963M
2 小林財団 6,000,000 8.07% ¥32.6B ¥624M
3 日本マスタートラスト信託銀行 5,246,000 7.06% ¥28.5B ¥546M
4 オアシスジャパンストラテジックファンド 3,855,000 5.19% ¥20.9B ¥401M
5 Ikuko Watanabe 2,325,000 3.13% ¥12.6B ¥242M
6 Forum 2,071,000 2.79% ¥11.2B ¥215M
7 オアシスジャパンストラテジックファンドY 2,039,000 2.74% ¥11.1B ¥212M
8 オアシスインベストメントIIマスターファンド 1,946,000 2.62% ¥10.6B ¥202M
9 Yukako Iueki 1,863,000 2.51% ¥10.1B ¥194M
10 Keiko 1,700,000 2.29% ¥9.2B ¥177M

Officers' holdings and pay

NameTitleSharesValuePay
大田 嘉仁 Chairman of the Board 1,000 ¥5.4M —
豊田 賀一 President & Representative Director 4,000 ¥21.7M —
松嶋 雄司 Director — — —
Akihiro Kobayashi Director 9,264,000 ¥50.3B —
片江 善郎 Outside Director — — —
髙橋 昭夫 Outside Director — — —
毛利 正人 Outside Director — — —
松本 真輔 Outside Director — — —
楠本 美砂 Outside Director — — —
門川 俊明 Outside Director — — —
山脇 明敏 Full-time Audit & Supervisory Board Member 2,000 ¥10.9M —
川西 貴 Full-time Audit & Supervisory Board Member 1,000 ¥5.4M —
八田 陽子 Outside Audit & Supervisory Board Member — — —
森脇 純夫 Outside Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 ¥5,426 ¥49.19 110.3x ¥104.0 78,050,000
FY ending Dec 2024 ¥6,229 ¥135.42 46.0x ¥102.0 78,050,000
FY ending Dec 2023 ¥6,784 ¥268.16 25.3x ¥101.0 78,050,000
FY ending Dec 2022 ¥9,035 ¥259.63 34.8x ¥90.0 78,050,000
Source: annual securities reports on EDINET. Values are estimates. Methodology